The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition Takehiko SakaiGoro KutomiShigehira Saji Special Article 16 October 2023 Pages: 1 - 7
The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition Naoko HonmaMasayuki YoshidaShigehira Saji Special Article Open access 07 November 2023 Pages: 8 - 15
Annual report of the Japanese Breast Cancer Registry for 2019 Minoru MiyashitaHiraku KumamaruShigehira Saji Special Article 04 December 2023 Pages: 16 - 23
Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography Takayoshi Uematsu Review Article Open access 12 October 2023 Pages: 24 - 30
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer Yoshitaka FujikiMasahiro KashiwabaYasuaki Sagara Original Article Open access 09 October 2023 Pages: 31 - 41
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study Linghui KongZhen YangHuijun Zhang Original Article 13 October 2023 Pages: 42 - 52
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole Masato TakahashiTomofumi OsakoNorikazu Masuda Original Article Open access 26 October 2023 Pages: 53 - 62
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer Asumi IesatoAtsushi FushimiNami Yamashita Original Article Open access 23 November 2023 Pages: 63 - 74
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study Masahiro YoshidaRyo-ichi YoshimuraWorking group of APBI with SAVIs in Japan (WASAVIs) Original Article 21 October 2023 Pages: 75 - 83
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy Mellissa WilliamsonDavid J. PressKaustubh Gururaj Original Article Open access 01 November 2023 Pages: 84 - 95
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer Xiaowei ShenGanggang WangWeixing Shen Original Article 02 November 2023 Pages: 96 - 104
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan Yoshitaka NishikawaNobukazu AgatsumaTakeo Nakayama Original Article Open access 20 November 2023 Pages: 105 - 115
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels Amira FathyMohamed A. AbdelrazekMohamed El-Far Original Article Open access 16 November 2023 Pages: 116 - 123
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study Florian PelzerWilfried TrögerDaniela Paepke Original Article Open access 15 November 2023 Pages: 124 - 134
IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G Rui JingShukun BaiGuoxu Zheng Original Article Open access 19 November 2023 Pages: 135 - 147
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer Helle PappotBenóný P. BjörnssonCecilie Holländer-Mieritz Rapid Communication 08 November 2023 Pages: 148 - 153
Comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Yoshiya Horimoto Letter to the Editor 20 November 2023 Pages: 154 - 154
Are breast cancer subtypes different in breast cancer patients with and without hepatitis C virus infection? Kadri Altundag Letter to the Editor 09 December 2023 Pages: 155 - 155